BRIVARACETAM ZENTIVA 50 mg, film-coated tablet 56 tablets
Active ingredients: BRIVARACÉTAM
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BRIVARACETAM ZENTIVA 50 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polychlortrifluoroéthylène aluminium de 56 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 21 Sept 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63887786CIP73032061CIP133400930320617Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BRIVARACÉTAMcomprimé | 50 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: BRIVARACETAM 50 mg - BRIVIACT 50 mg, comprimé pelliculé